New Research Poster Presentation 2.33
A Randomized, Placebo-Controlled Study of Duloxetine for the Treatment of Children (7-11 Years) and Adolescents (12-17 Years) with Generalized Anxiety Disorder

Thursday, October 24, 2013
Jeffrey Robert Strawn, MD, University of Cincinnati, Cincinnati, OH
Apurva Prakash, BA, Eli Lilly and Company, Indianapolis, IN
Qi Zhang, PhD, Eli Lilly and Company, Indianapolis, IN
Beth A. Pangallo, RN, Eli Lilly and Company, Indianapolis, IN
Chad Stroud, PharmD, Eli Lilly and Company, Indianapolis, IN
Na Cai, PhD, Eli Lilly and Company, Indianapolis, IN
Robert L. Findling, MD, MBA, Department of Psychiatry, The Johns Hopkins University/Kennedy Kreiger Institute, Baltimore, MD
See more of: New Research Posters Session 2
See more of: New Research Poster
Copyright ©2013 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.